ChiCTR1900024349
尚未开始
/
/
/
2019-07-06
/
/
Dementia
The Hong Kong Mental Morbidity Survey for Older People
The Hong Kong Mental Morbidity Survey for Older People
Population ageing has become a major public health concern. Dementia and mental disorders affect independent functioning and pose significant burden to the patients and their families. With changing demographics in the Hong Kong ageing community, an update on prevalence estimates of dementia and late life mental disorders is required for good health care planning. The Hong Kong Mental Morbidity Survey for Older People (HKMMSOP) aims to evaluate: 1) prevalence of dementia and its subtypes, common mental disorders and psychosis syndromes in Hong Kong adults aged 60 or over; 2) modulating factors for disease development or functional optimization; 3) disease burden and cost of care.
连续入组
其它
N/A
N/A
Health and Medical Research Fund
/
6000
/
2019-07-09
2021-06-30
/
1. Aged 60 years or over; 2. Consent for participation. For subjects who are willing to participate, but are unavailable or unable to provide full information (e.g. profound cognitive impairments or sensory deficits), proxy information from first degree relatives will be obtained and the data will be specified as proxy.；
登录查看Those who are non-Chinese and the prison population will not be covered in this survey.；
登录查看Food and Health Bureau, Hong Kong SAR Government
/
精准药物2024-11-23
亚泰制药2024-11-23
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
